Skip to main content
Log in

Effect of Lipoprotein-X on lipid metabolism in rat kidney

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Lipoprotein-X (Lp-X) is found in the plasma of patients with familiallecithin: cholesterol acyltransferase (LCAT) deficiency syndromes. Themajority of the patients with this disorder develop progressiveglomerulosclerosis. In this study, the effect of Lp-X on lipid metabolism inperfused rat kidney was investigated. Lp-X was isolated from plasma ofpatients with familial LCAT deficiency by sequential ultracentrifugation andgel filtration column chromatography. Rat kidneys were perfused for 1-2 hwith Krebs-Henseleit buffer containing 20 µM [1-14C]acetate or 20µM [Me-3H]choline. In the presence of Lp-X, no significant differencein the incorporation of radioactivity into triglycerides, cholesterol,phosphocholine, CDP-choline and sphingomyelin was observed. However,incorporation of radioactivity into cholesteryl esters andphosphatidylcholine was significantly elevated in Lp-X perfused kidneys. Thecontents of cholesterol, cholesteryl esters and phosphatidylcholine werealso significantly increased in Lp-X perfused kidneys. The increase in lipidcontent in the Lp-X perfused kidney is attributed to the direct depositionof Lp-X lipids into the organ. The increase in the labelling of cholesterylesters was attributed to the increase of available substrate (cholesterol)for the acyl-CoA:cholesterol acyltransferase (ACAT) reaction. The increasein phosphatidylcholine labelling was caused by a reduced turnover of thenewly synthesized labelled phosphatidylcholine during Lp-X perfusion.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Glomset JA, Assmann G, Gjone E, Norum KR: Lecithin:cholesterol acyltransferase deficiency and fish eye disease. In: CR Scriver, AL Beaudet, WS Sly, D Valle (eds). The Metabolic Basis of Inherited Disease. McGraw-Hill, Inc., New York, 1995, pp 1933–1951

    Google Scholar 

  2. Torsvik H, Berg K, Magnani HN, McConathy WJ, Alaupovic P, Gjone E: Identification of the abnormal cholestatic lipoprotein (Lp-X) in familial lecithin:cholesterol acyltransferase deficiency. FEBS Lett 24:165–167, 1972

    Google Scholar 

  3. Seidel D, Gjone E, Blomhoff JP, Geisen HP: Plasma lipoproteins in patients with familial plasma lecithin:cholesterol acyltransferase (LCAT) deficiency–studies on the apolipoprotein composition of isolated fractions with identification of Lp-X. Horm Metab Res Suppl 4: 6–11, 1974

    Google Scholar 

  4. Ritland S, Gjone E: Quantitative studies of lipoprotein-X in familial lecithin:cholesterol acyltransferase deficiency and during cholesterol esterification. Clin Chem Acta 59: 109–119, 1975

    Google Scholar 

  5. Guerin M, Dolphin PJ, Chapman MJ: Familial lecithin:cholesterol acyltransferase deficiency: Further resolution of lipoprotein particle heterogeneity in the low density interval. Atherosclerosis 104: 195–212, 1993

    Google Scholar 

  6. Norum KR, Gjone E: Familial plasma lecithin:cholesterol acyltransferase deficiency. Biochemical study of a new inborn error of metabolism. Scand J Clin Lab Invest 20: 231–243, 1967

    Google Scholar 

  7. McLean JW: Molecular defects in the lecithin:cholesterol acyltransferase gene. In: NE Miller, AR Tall (eds). High Density Lipoproteins and Atherosclerosis III. Elsevier Science Publishers B.V. Amsterdam, 1992, pp 59–65

    Google Scholar 

  8. Klein H-G, Lohse P, Duverger N, Albers JJ, Rader DJ, Zech LA, Santamarina-Fojo S, Brewer Jr HB: Two different allelic mutations in the lecithin:cholesterol acyltransferase (LCAT) gene resulting in classic LCAT deficiency: LCAT(tyr83-stop) and LCAT(tyr156-asn). J Lipid Res 34: 49–58, 1993

    Google Scholar 

  9. Frohlich J, McLeod R, Pritchard PH, Fesmire J, McConathy W: Plasma lipoprotein abnormalities in heterozygotes for familial lecithin: cholesterol acyltransferase deficiency. Metabolism 37: 3–8, 1988

    Google Scholar 

  10. Hoving T, Gjone E: Familial plasma lecithin:cholesterol acyltransferase (LCAT) deficiency: Ultrastructural aspects of a new syndrome with particular reference to lesions in the kidneys and the spleen. Acta Pathol Microbiol Scand Section A 81: 681–697, 1973

    Google Scholar 

  11. Gjone E, Blomhoff J, Skarbovik AJ: Possible association between an abnormal low density lipoprotein and nephropathy in lecithin:cholesterol acyltransferase deficiency. Clin Chim Acta 54: 11–18, 1974

    Google Scholar 

  12. Stokke KT, Bjerve KS, Blomhoff JP, Oystese B, Flatmark A, Norum KR, Gjone E: Familial lecithin:cholesterol acyltransferase deficiency: Studies on lipid composition and morphology of tissues. J Clin Lab Invest 33: 93–100, 1974

    Google Scholar 

  13. Flatmark AL, Hovig T, Myhre E, Gjone E: Renal transplantation in patients with familial lecithin:cholesterol-acetyltransferase deficiency. Transplantation Proceedings IX: 1665–1671, 1977

    Google Scholar 

  14. Myhre E, Gjone E, Flatmark A, Hovig T: Renal Failure in familial lecithin-cholesterol acyltransferase deficiency. Nephron 18: 239–248, 1977

    Google Scholar 

  15. Magil A, Chase W, Frohlich J: Unusual renal biopsy findings in a patient with familial lecithin:cholesterol acyltransferase deficiency. Hum Pathol 13: 283–285, 1982

    Google Scholar 

  16. Ohta Y, Yamamoto S, Ysuchida H, Murano S, Saitoh Y, Yohjo S, Okada M: Nephropathy of familial lecithin-cholesterol acyltransferase deficiency: Report of a case. Am J Kidney Diseases VII: 41–46, 1986

    Google Scholar 

  17. Weber P, Owen JS, Desai K, Clemens MR: Hereditary lecithin: cholesterol acyltransferase deficiency: Case report of a German patient. Am J Clin Pathol 88: 510–516, 1987

    Google Scholar 

  18. Horina JH, Wirnsberger G, Horn S, Roob JM, Ratschek M, Holzer H, Pogglitsch H, Krejs GJ: Long-term follow-up of a patient with lecithin:cholesterol acyltransferase deficiency syndrome after kidney transplantation. Transplantation 56: 322–326, 1993

    Google Scholar 

  19. Sabesin SM: Cholestatic lipoproteins-their pathogenesis and significance. Gastroenterology 83: 704–709, 1982

    Google Scholar 

  20. Miller JP: Dyslipoproteinaemia of liver disease. Bailliere's Clin Endocrinology Met 4: 807–833, 1990

    Google Scholar 

  21. Narayanan S: Biochemistry and clinical relevance of Lipoprotein X. Ann Clin Lab Sci 14: 371–374, 1984

    Google Scholar 

  22. Patsch JR, Aune KC, Gotto Jr AM, Morrisett JD: Isolation, chemical characterization, and biophysical properties of three different abnormal lipoproteins: Lp-X1, Lp-X2, and Lp-X3. J Biol Chem 252: 2113–2120, 1977

    Google Scholar 

  23. OK, Frohlich J: Role of lecithin:cholesterol acyltransferase and apolipoprotein A-I in cholesterol esterification in Lipoprotein-X in vitro. J Lipid Res 36: 2344–2354, 1995

    Google Scholar 

  24. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with Folin phenol reagent. J Biol Chem 193: 265–275, 1951

    Google Scholar 

  25. Wengeler H, Seidel D: Does Lipoprotein-X (Lp-X) act as a substrate for the lecithin:cholesterol acyltransferase (LCAT)? Clin Chim Acta 45: 429–432, 1973

    Google Scholar 

  26. Patsch JR, Soutar AK, Morrissett JD, Gotto AM Jr, Smith LC: Lipoprotein-X: A substrate for lecithin:cholesterol acyltransferase. Eur J Clin Invest 7: 213–217, 1977

    Google Scholar 

  27. Patsch W, Patsch JR, Kunz F, Sailer S, Braunsteiner H: Studies on the degradation of Lipoprotein-X. Eur J Clin Invest 7: 523–530, 1977

    Google Scholar 

  28. Ritland S, Gjone E: Quantitative studies of Lipoprotein-X in familial lecithin:cholesterol acyltransferase deficiency and during cholesterol esterification. Clin Chim Acta 59: 109–119, 1975

    Google Scholar 

  29. Bowman RH, Maack T: Glucose transport by the isolated perfused rat kidney. Am J Physiol 222: 1499–1504, 1972

    Google Scholar 

  30. Anderson RL, Davis S: An organic phosphorus assay which avoid the use of hazardous perchloric acid. Clin Chim Acta 121: 111–116, 1982

    Google Scholar 

  31. Cao YZ, O K, Choy PC, Chan AC: Regulation by vitamin E of phosphatidylcholine metabolism in rat heart. Biochem J 247: 135–140, 1987

    Google Scholar 

  32. Michael P, Gillett T, Owen JS: Cholesterol esterifying enzymeslecithin: cholesterol acyltransferase (LCAT) and acylcoenzyme A:cholesterol acyltransferase (ACAT). In: CA Converse, ER Skinner (eds). Lipoprotein Analysis A Practical Approach. IRL Press, Oxford, 1992, pp 187–201

    Google Scholar 

  33. Kraemer FB, Patel S, Saedi MS, Sztalryd C: Detection of hormonesensitive lipase in various tissues. I. Expression of an HSL/bacterial fusion protein and generation of anti HSL antibodies. J Lipid Res 34: 663–671, 1993

    Google Scholar 

  34. Choy PC, Tardi PG, Mukherjee JJ: Lysophosphatidylcholine acyltransferase. Meth Enzymol 209: 80–86, 1992

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Karmin, O., Ly, M., Fang, D.Z. et al. Effect of Lipoprotein-X on lipid metabolism in rat kidney. Mol Cell Biochem 173, 17–24 (1997). https://doi.org/10.1023/A:1006836704042

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006836704042

Navigation